Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001286928 | SCV001473557 | uncertain significance | Congenital dyserythropoietic anemia, type I | 2020-02-18 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003145510 | SCV003829415 | uncertain significance | Anemia, congenital dyserythropoietic, type 1a | 2023-01-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003346427 | SCV004068580 | uncertain significance | Inborn genetic diseases | 2023-07-31 | criteria provided, single submitter | clinical testing | The c.845G>A (p.R282Q) alteration is located in exon 4 (coding exon 4) of the CDAN1 gene. This alteration results from a G to A substitution at nucleotide position 845, causing the arginine (R) at amino acid position 282 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |